Prior to Penn, he was at Third Rock Ventures, a life sciences venture capital firm, and served on the founding management team of SAGE Therapeutics, a company developing medicines for rare nervous system disorders. He has also held engineering roles at IBM. Brian received his B.S. in Chemistry from Stanford University and his Ph.D. from the MIT Media Laboratory, where he also conducted his postdoctoral training, jointly with the Department of Biological Engineering and McGovern Institute for Brain Sciences. Research Scientists and Post-doctoral Fellows